In Vitro Assessment of Mutagenic And Genotoxic Effects of Coumarin Derivatives 6,7-Dihydroxycoumarin and 4-Methylesculetin

REFERENCES

• Api, A. M. 2001. Lack of effect of coumarin on the formation of micronuclei in an in vivo mouse micronucleus assay. Food Chem. Toxicol. 39: 837 –841.
   PubMed Web of Science ®Google Scholar
• Baba, M., Jin, Y., Mizuno, A., Suzuki, H., Okada, Y., Takasuka, N., Tokuda, H., Nishino, H., and Okuyama, T. 2002. Studies on cancer chemoprevention by traditional folk medicines XXIV. Inhibitory effect of a coumarin derivative, 7-isopentenyloxycoumarin, against tumor promotion. Biol. Pharm. Bull. 25: 244 –246.
   PubMed Web of Science ®Google Scholar
• Beillerot, A., Domínguez, J. C. R., Kirsch, G., and Bagrel, D. 2008. Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin. Bioorg. Med. Chem. Lett. 18: 1102 –1105.
   PubMed Web of Science ®Google Scholar
• Berenbaum, M. 1995. Phototoxicity of plant secondary metabolites: Insect and mammalian perspectives. Arch. Insect Biochem. Physiol. 29: 119 –134.
   PubMed Web of Science ®Google Scholar
• Bernstein, L., Kaldor, J., Mccann, J., and Pike, M. C. 1982. An empirical approach to the statistical analysis of mutagenesis data from Salmonella test. Mutat. Res. 97: 267 –281.
   PubMed Web of Science ®Google Scholar
• Born, S. L., Hu, J. K., and Lehman-McKeeman, L. D. 2000. o-Hydroxyphenylacetaldehyde is a hepatotoxic metabolite of coumarin. Drug Metab. Dispos. 28: 218 –223.
   PubMed Web of Science ®Google Scholar
• Broadhead, C. L., and Combes, R. D. 2001. The current status for food additives toxicity testing and the potential for application of the three Rs. ATLA 29: 471 –485.
   Google Scholar
• Cai, Y., Kleiner, H., Johnston, D., Dubowski, A., Bostic, S., Ivie, W., and DiGiovanni, J. 1997. Effect of naturally occurring coumarins on the formation of epidermal DNA adducts and skin tumors induced by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis 18: 1521 –1527.
   PubMed Web of Science ®Google Scholar
• Casley-Smith, J. R. 1999. Benzo-pyrones in the treatment of lymphoedema. Int. Angiol. 18: 31 –41.
   PubMed Web of Science ®Google Scholar
• Claxton, L. D., Stead, A. G., and Walsh, D. 1988. An analysis by chemical class Salmonella mutagenicity tests as precictors as animal carcinogenicity. Mutat. Res. 205: 1 –4.
   PubMed Web of Science ®Google Scholar
• Fedato, R. P., and Maistro, E. L. 2014. Absence of genotoxic effects of the coumarin derivative 4-methylesculetin in vivo and its potential chemovenction against doxorubicin-induced DNA damage. J. Appl. Toxicol. 34: 33 –39.
   PubMed Web of Science ®Google Scholar
• Fenech, M. 2000. The in vitro micronucleus technique. Mutat. Res. 455: 81 –95.
   PubMed Web of Science ®Google Scholar
• Francisco, C. S., Rodrigues, L. R., Cerqueira, N. M., Oliveira-Campos, A. M., and Rodrigues, L. M. 2012. Synthesis of novel benzofurocoumarin analogues and their anti-proliferative effect on human cancer cell lines. Eur. J. Med. Chem. 47: 370 –376.
   PubMed Web of Science ®Google Scholar
• Guo, L. Q., and Yamazoe, Y. 2004. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol. Sin. 25: 129 –136.
   PubMed Web of Science ®Google Scholar
• Hartmann, A., and Speit, G. 1997. The contribution of cytotoxicity to DNA—Effects in the single cell gel test (comet assay). Toxicol. Lett. 90: 183 –188.
   PubMed Web of Science ®Google Scholar
• Iranshari, M., Askari, M., Sahebkar, A., and Hadjipavlou-Litina, D. 2009. Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. DARU J. Pharm. Sci. 17: 99 –103.
   Google Scholar
• Kelly, V. P., Ellis, E. M., Manson, M. M., Chanas, S. A., Moffat, G. J., McLeod, R., Judah, D. J., Neal, G. E., and Hayes, J. D. 2000. Chemoprevention of aflotoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Cancer Res. 60: 957 –969.
   PubMed Web of Science ®Google Scholar
• Kim, S. N., Kim, N. H., Park, Y. S., Kim, H., Lee, S., Wang, Q., and Kim, Y. K. 2009. 7-Diethylamino-3(2ʹ-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells. Biochem. Pharmacol. 77: 1773 –1779.
   PubMed Web of Science ®Google Scholar
• Kleiner, H. E., Vulimiri, S. V., Starost, M. F., Reed, M. J., and DiGiovanni, J. 2002. Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis 23: 1667 –1675.
   PubMed Web of Science ®Google Scholar
• Lake, B. 1999. Coumarin metabolism, toxicity, and carcinogenicity: Relevance for human risk assessment. Food Chem. Toxicol. 37: 423 –453
   PubMed Web of Science ®Google Scholar
• Lake, B. G., and Grasso, P. 1996. Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: A dose and time response study. Fundam. Appl. Pharmacol. 97: 311 –323.
   Google Scholar
• Maron, D. M., and Ames, B. N. 1983. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113: 173 –215.
   PubMed Web of Science ®Google Scholar
• Mitra, I., Saha, A., and Roy, K. 2013. Predictive modeling of antioxidant coumarin derivatives using multiple approaches: Descriptor-based QSAR, 3D-pharmacophore mapping, and HQSAR. Sci. Pharm. 81: 57 –80.
   PubMedGoogle Scholar
• Morris, D. L., and Ward, J. B. 1992. Coumarin inhibts micronuclei formation induced by benzo(a)pyrene in male but not female ICR mice. Environ. Mol. Mutagen. 19: 132 –138.
   PubMed Web of Science ®Google Scholar
• Murray, R. D. H., Mendez, J., and Brown, S. A., eds. 1982. The natural coumarins: Occurrence, chemistry and biochemistry, 97 –111. New York, NY: John Wiley & Sons.
   Google Scholar
• National Toxicology Program. 1993. Toxicology and carcinogenic studies of coumarin (CAS No. 91-64-5) in F344/N mice and B6C3F1 mice (gavage studies). Technical report series no. 422. NIH Publication No. 92-31153. Bethesda, MD: U.S. Department of Health and Human Services.
   Google Scholar
• Ngwendson, J. N., Bedir, E., Efange, S. M., Okunji, C. O., Iwu, M. M., Schuster, B. G., and Khan, I. 2003. Constituents of Peucedanum zenkeri seeds and their antimicrobial effects. Pharmazie 58: 587 –589.
   PubMed Web of Science ®Google Scholar
• Organization for Economic Cooperation and Development. 1997. Guideline for testing of chemicals, Test guideline 471: Bacterial reverse mutation test. Paris, France: OECD.
   Google Scholar
• Panda, S. K., Kumar, S., Tupperwar, N. C., Vaidya, T., George, A., Rath, S., Bal, V., and Ravindran, B. 2012. Chitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemia. PLoS Pathol. 8: e1002717.
   PubMed Web of Science ®Google Scholar
• Prince, M., Campbell, C. T., Robertson, T. A., Wells, A. J., and Kleiner, H. E. 2006. Naturally occurring coumarins inhibit 7,12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland. Carcinogenesis 27: 1204 –1213.
   PubMed Web of Science ®Google Scholar
• Resende, F. A., Munari, C. C., Bentos, M. N. A., Tavares, D. C., Bastos, J. K., Silva-Filho, A. A., and Varanda, E. A. 2012. Comparative studies of the (anti) mutagenicity of Baccharis dracunculifolia and artepillin c by the bacterial reverse mutation test. Molecules 7: 2335 –2350.
   Web of Science ®Google Scholar
• Setzer, W. N., Setzer, M. C., Schmidt, J. M., Moriarity, D. M., Vogler, B., Reeb, S., Holmes, A. M., and Haber, W. A. 2000. Cytotoxic components from the bark of Stauranthus perforatus from Monteverde, Costa Rica. Planta Med. 66: 493 –494.
   PubMed Web of Science ®Google Scholar
• Singh, N. P., McCoy, M. T., Tice, R. R., and Schneider, E. L. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175: 184 –191.
   PubMed Web of Science ®Google Scholar
• Strober, W. 1997. Trypan blue exclusion test of cell viability. Curr. Prot. Immunol. A.3B.1–A.3B.2.
   Google Scholar
• Tanaka, T., Kawabata, K., Kakumoto, M., Hara, A., Murakami, A., Kuki, W., Takahashi, Y., Yonei, H., Maeda, M., Ota, T., Odashima, S., Yamane, T., Koshimizu, K., and Ohigashi, H. 1998. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: The inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res. 58: 2550 –2556.
   PubMed Web of Science ®Google Scholar
• Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J. C., and Sasaki, Y. F. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35: 206 –221.
   PubMed Web of Science ®Google Scholar
• Venugopala, K. N., Rashmi, V., and Odhav, B. 2013. Review on natural coumarin lead compounds for their pharmacological activity. Biol. Med. Res. Int. 2013: 1 –14.
   Web of Science ®Google Scholar
• Vianna, D. R., Bulobs, G., Meirelles, G., Silva, B. V., Rocha, A., Lanznaster, M., Monserrat, J. M., Garcia, S. C., Poser, G. V., and Eifler-Lima, V. L. 2012. Evaluation of the antioxidant capacity of synthesized coumarins. Int. J. Mol. Sci. 13: 7260 –7270.
   PubMed Web of Science ®Google Scholar
• Wattenberg, L. W., Lam, L. K., and Fladmoe, A. V. 1979. Inhibition of chemical carcinogen-induced neoplasia by coumarins and alpha-angelicalactone. Cancer Res. 39: 1651 –1654.
   PubMed Web of Science ®Google Scholar